CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Nouveau Life Pharmaceuticals Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Nouveau Life Pharmaceuticals Inc
237 Main Street, Box 880
Phone: (888) 550-2333p:888 550-2333 NIVERVILLE, MB  R0A 1E0  Canada Ticker: HRID HRID

Business Summary
Nouveau Life Pharmaceuticals, Inc. is a Canada-based company. The Company has not commenced its business operations.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
3/31/20086/30/2007YesYes---

Industries
SIC Code Description
6726 Unit investment trusts, face-amount certificate offices

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
President, Chief Executive Officer MelissaWalker 5/9/2012 5/9/2012
Chief Financial Officer, Director DouglasDickie 60 12/6/2011 4/12/2006
Vice President, Treasurer, Secretary, Director RollyHein 66 4/12/2006 4/12/2006
Director EdwardMelenka 72 7/12/2006 7/12/2006

Business Names
Business Name
HRID
Hybrid Fuels (Canada) Inc.
Hybrid Fuels Inc.
NOUV
Nouveau Life Pharmaceuticals, Inc.

General Information
Outstanding Shares: 6,660,963,733 (As of 3/31/2022)
Shareholders: 262
Stock Exchange: OTC
Federal Tax Id: 880384399


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, August 28, 2023